A. Mark Demitrack's Insider Trades & SAST Disclosures
A. Mark Demitrack's most recent trade in Trevena Inc was a trade of 532 Common Stock done at an average price of $1.5 . Disclosure was reported to the exchange on Oct. 8, 2024.
Add Superstar Alert
Share
Note
This is a custom search result for pattern A. Mark Demitrack.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Trevena Inc | Mark A. Demitrack | Acting CMO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.47 per share. | 08 Oct 2024 | 532 | 11,363 (0%) | 0% | 1.5 | 782 | Common Stock |
| Trevena Inc | Mark A. Demitrack | Acting CMO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.47 per share. | 08 Oct 2024 | 144 | 11,895 (0%) | 0% | 1.5 | 212 | Common Stock |
| Trevena Inc | Mark A. Demitrack | Acting CMO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.47 per share. | 08 Oct 2024 | 144 | 12,039 (0%) | 0% | 1.5 | 212 | Common Stock |
| Trevena Inc | Mark A. Demitrack | Acting CMO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.47 per share. | 08 Oct 2024 | 45 | 12,183 (0%) | 0% | 1.5 | 66 | Common Stock |
| Trevena Inc | Mark A. Demitrack | Acting CMO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.45 per share. | 08 Oct 2024 | 20 | 12,228 (0%) | 0% | 1.5 | 29 | Common Stock |
| Trevena Inc | Mark A. Demitrack | SVP, Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.61 per share. | 02 Dec 2023 | 185,000 | 259,817 (0%) | 0% | 0.6 | 112,850 | Common Stock |
| Trevena Inc | Mark Demitrack A. | SVP, Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.61 per share. | 02 Dec 2023 | 50,000 | 309,817 (0%) | 0% | 0.6 | 30,500 | Common Stock |
| Trevena Inc | A. Mark Demitrack | SVP, Chief Medical Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.61 per share. | 02 Dec 2023 | 3,593 | 306,224 (0%) | 0% | 0.6 | 2,192 | Common Stock |
| Trevena Inc | Mark Demitrack A. | SVP, Chief Medical Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.59 per share. | 02 Dec 2023 | 3,593 | 74,817 (0%) | 0% | 0.6 | 2,120 | Common Stock |
| Trevena Inc | A. Mark Demitrack | SVP, Chief Medical Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.59 per share. | 02 Dec 2023 | 1,121 | 78,410 (0%) | 0% | 0.6 | 661 | Common Stock |
| Trevena Inc | Mark Demitrack A. | SVP, Chief Medical Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.59 per share. | 02 Dec 2023 | 497 | 79,531 (0%) | 0% | 0.6 | 293 | Common Stock |
| Trevena Inc | Mark A. Demitrack | SVP, Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jan 2023 | 50,000 | 80,028 (0%) | 0% | 0 | Common Stock | |
| Trevena Inc | Mark A. Demitrack | SVP, Chief Medical Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.55 per share. | 17 Dec 2022 | 497 | 30,028 (0%) | 0% | 1.5 | 770 | Common Stock |
| Trevena Inc | Mark A. Demitrack | SVP, Chief Medical Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 3.42 per share. | 02 Dec 2022 | 1,121 | 30,525 (0%) | 0% | 3.4 | 3,834 | Common Stock |
| Trevena Inc | Mark A. Demitrack | SVP, Chief Medical Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.65 per share. | 06 Dec 2021 | 30,601 | 803,580 (0%) | 0% | 0.7 | 19,891 | Common Stock |
| Trevena Inc | Mark A. Demitrack | SVP, Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Dec 2021 | 390,000 | 834,181 (0%) | 0% | 0 | Common Stock | |
| Trevena Inc | Mark A. Demitrack | Sr. VP & Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Dec 2020 | 259,100 | 259,100 | - | - | Stock Option (Right to Buy) | |
| Trevena Inc | Mark A. Demitrack | Sr. VP & Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Dec 2020 | 172,700 | 444,181 (0%) | 0% | 0 | Common Stock | |
| Trevena Inc | Mark A. Demitrack | Sr. VP & Chief Medical Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.27 per share. | 07 Dec 2020 | 48,557 | 271,481 (0%) | 0% | 2.3 | 110,224 | Common Stock |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges